JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
Equities
000623
CNE000000719
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.99 CNY | +0.20% |
|
-0.60% | -0.99% |
| 04-29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
ETFs positioned on Jilin Aodong Pharmaceutical Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 112 M€ | +4.66% | - | |
| 0.00% | 7 M€ | +5.02% | - | |
| 0.00% | 32 M€ | +7.81% | - | |
| 0.00% | 34 M€ | +3.48% | - |
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows:
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.99
CNY
Average target price
22.67
CNY
Spread / Average Target
+51.23%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -0.99% | 2.48B | |
| +29.39% | 682B | |
| +30.35% | 586B | |
| -3.52% | 364B | |
| +17.83% | 327B | |
| +3.88% | 285B | |
| +15.77% | 240B | |
| +10.32% | 209B | |
| -8.34% | 203B | |
| +7.33% | 165B |
- Stock Market
- Equities
- 000623 Stock
- Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
